Precigen (PGEN) Gross Profit (2013 - 2026)

Precigen (PGEN) reported Gross Profit of $20.7 million for Q1 2026, up 8486.31% year-over-year from $241000.0 in Q1 2025, and up 596.97% quarter-over-quarter from $3.0 million in Q4 2025.

Precigen (PGEN) Gross Profit (2013 - 2026) Analysis & Trends

Precigen (PGEN) has 14 years of Gross Profit data on file, last reported at $20.7 million in Q1 2026.

  • Gross Profit for Q1 2026 came in at $20.7 million, up 8486.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.6 million (up 39116.36% YoY), and the FY2025 annual result was $4.9 million, up 1521.35% from the prior year.
  • Gross Profit improved to $20.7 million in Q1 2026 per PGEN's latest filing, from $3.0 million in the prior quarter.
  • Over five years, Gross Profit peaked at $20.7 million in Q1 2026 and troughed at -$15.6 million in Q4 2022.
  • A 5-year average of $436058.8 and a median of -$123000.0 in 2024 frame the typical range for Gross Profit.
  • The sharpest annual moves came in 2023 and 2026: Gross Profit plunged 987.86% in 2023, then jumped 8486.31% in 2026.
  • A 5-year view of Gross Profit shows it stood at -$15.6 million in 2022, then soared by 99.16% to -$130000.0 in 2023, then surged by 313.85% to $278000.0 in 2024, then soared by 967.99% to $3.0 million in 2025, then surged by 596.97% to $20.7 million in 2026.
  • Business Quant data shows PGEN's Gross Profit at $20.7 million in Q1 2026, $3.0 million in Q4 2025, and -$1.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 20.69 Mn
Mar 31, 2026 20.69 Mn
Dec 31, 2025 2.97 Mn
Dec 31, 2025 2.97 Mn
Sep 30, 2025 -1.04 Mn
Sep 30, 2025 -1.04 Mn
Jun 30, 2025 -1.06 Mn
Jun 30, 2025 -1.06 Mn
Mar 31, 2025 241,000.00
Mar 31, 2025 241,000.00
Dec 31, 2024 278,000.00
Dec 31, 2024 278,000.00
Sep 30, 2024 -123,000.00
Sep 30, 2024 -123,000.00
Jun 30, 2024 -341,000.00
Jun 30, 2024 -341,000.00
Mar 31, 2024 -937,000.00
Mar 31, 2024 -937,000.00
Dec 31, 2023 -130,000.00
Dec 31, 2023 -130,000.00